Back to HHLR Advisors, Ltd. HHLR Advisors, Ltd.

LEGNLEGN

Showing 8 of 25 quarters

Position history for HHLR Advisors, Ltd.HHLR Advisors, Ltd.'s holdings in Legend Biotech Corporation

Yes. HHLR Advisors holds 5,984,550 shares of LEGN (Legend Biotech), worth $172.8M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. HHLR Advisors has held LEGN in every 13F on record since Q2 2020, 25 quarterly filings. LEGN is 20.8% of HHLR Advisors' reported 13F portfolio.

Current Value

$172.8M

Current Shares

6M

Total Value Change

-$150.6M

Total Shares Change

-651,946

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
6M
0.0%
$172.8M20.8%$28.88
0
2026-Q1
Unchanged
6M
0.0%
$108.3M6.5%$17.86
0
2025-Q4
Unchanged
6M
0.0%
$130.1M4.2%$21.53
0
2025-Q3
Unchanged
6M
0.0%
$195.2M4.8%$32.85
0
2025-Q2
Unchanged
6M
0.0%
$212.4M6.8%$34.63
0
2025-Q1
Unchanged
6M
0.0%
$203.1M5.7%$35.06
0
2024-Q4
Decreased
6M
-9.8%
$194.7M6.7%$32.77
0
2024-Q3
Unchanged
6.6M
0.0%
$323.4M7.1%$49.27
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used